Partnerships

Celebrating Local Success Towards Cervical Cancer Elimination

November 2023

MSD has launched the Race to Elimination campaign to showcase local areas on the road to cervical cancer elimination, and inspire country-wide action of the NHS England elimination pledge.

99.8% of cervical cancer cases are entirely preventable,^[1]providing a unique opportunity – through Human Papillomavirus (HPV) vaccination and cervical screening – to eliminate the impact of this disease on women, their families and society. This opportunity is recognised at the highest level: in 2020, the World Health Organization (WHO) set global targets to work towards the elimination of cervical cancer – 90% of girls vaccinated, 70% of women screened, and 90% of those with cervical disease receiving treatment by 2030 ^[2]

On 15 November 2023, the UK joined the company of the WHO and other countries with the announcement of NHS England’s commitment to eliminate cervical cancer by 2040^[^3] . This is truly a significant step in the UK’s Race to Elimination.

Whilst this is a significant step, variation persists between local areas in cervical screening and HPV vaccination coverage rates.^[^4]^[5]The consequence of this is an estimated 850 cervical cancer deaths every year – more than two women every day – but with an effective strategy, the UK can close the gap with world leaders.

At MSD, we believe that – while learning from abroad is key – we should also be looking closer to home for inspiration. Local areas across the country are successfully increasing HPV vaccination coverage and cervical screening, while tackling the inequalities in access experienced by some communities. In this context, these pockets of good practice are meeting, or even exceeding, the WHO’s thresholds. In doing so, they are proof that hitting NHS England’s ambition to eliminate cervical cancer by 2040, is fully achievable.

The Race to Elimination campaign therefore aims to celebrate success in these trailblazing areas across the UK – seeking to understand not only the factors behind local progress, but the lessons that can be learned for the whole country. Ultimately, we want to inspire momentum towards the elimination of cervical cancer nationwide, making cervical cancer elimination a reality for women in every corner of the country.

The campaign’s journey will be taking us initially to the West Midlands, Northumberland, Greater Manchester, the Thames Valley, and Havering in London. Who will win the Race to Elimination?

[1] Cancer Research UK, Cervical cancer statistics. Last accessed August 2023.

[2] The World Health Organization, Global strategy to accelerate the elimination of cervical cancer as a public health problem, November 2020. Last accessed August 2023.

[3] NHS England. Last Accessed November 2023

[4] UK Health Security Agency, Human papillomavirus (HPV) vaccine coverage estimates in adolescents in England: academic year 2021 to 2022, December 2022. Last accessed August 2023.

[5] NHS Digital, Cervical Screening Programme, England – 2021-2022, November 2022. Last accessed August 2023.

GB-NON-08533 | November 2023

Partnerships

Building healthcare resilience for better, more equitable health

May 2023

The Covid-19 pandemic highlighted the importance of investing in healthcare resilience and shone a spotlight on how major health events exacerbate existing inequalities, disrupt essential services, and create new barriers to accessing healthcare.

Given the immediate challenges faced by health and care systems, notably the major workforce challenges and clearing the elective care backlog, we are naturally focused on finding solutions to immediate problems. However, is imperative that resources dedicated to long-term challenges are protected and that we invest in a sustainable and agile healthcare system that can meet the complex and changing needs of an ageing society.

Indeed, the recently published Hewitt Review of integrated care systems highlights the need to invest in prevention, population health management, and tackling health inequalities to promote health and reduce the gap in healthy life expectancy. The problem is well observed, but meaningful and sustained solutions driven by Integrated Care Systems have the power to make real change.

That said, no one organisation or institution has the knowledge or resources to resolve health challenges alone. Collaboration between the NHS, third sector, academia, government bodies, and industry will be essential to driving progress to improve healthcare resilience. So, in March, MSD sponsored a roundtable at the Nuffield Trust Summit that brought together health and care leaders to explore how, at a time of constrained public expenditure and health backlogs, health systems are working together to build healthcare resilience and prepare for future health challenges.

The discussion covered a diverse range of examples and recommendations, from placing inclusion at the heart of prevention approaches to empowering the healthcare workforce to make decisions at a local level with support from the centre where needed, to ensuring psychological safety in the health and care workforce – required to underpin progress.

At MSD, we recognise that we have an important role to play to support the healthcare resilience agenda:

We are investing in public health

Vaccines are one of the greatest public health success stories in history. MSD is the largest supplier of vaccines to the UK national immunisation programmes, helping to protect the public from infancy to adulthood. Through a number of activities, we are committed to partnering with the local and national health system to strengthen the UK’s response across vaccine-preventable diseases, by reducing inequalities in access to immunisation systems. To support the UK’s HPV elimination effort, we have invested in the development of a digital mapping tool to compare rates of cervical cancer, vaccination coverage rates, screening uptake, and different population characteristics, e.g. deprivation levels and ethnicity, across England. Working with the agency and the platform that developed a similar tool to aid the NHS roll-out of the COVID-19 vaccination programme, our tool gives a granular insight into how close or far localities are from achieving the critical pre-requisites for the elimination of cervical cancer, whilst also uncovering the extent of variation across the country.

We are focusing on future health challenges

As a founding industry member, MSD is supporting Our Future Health, the UK’s largest-ever health research programme, which aims to transform the detection, prevention, and treatment of a wide range of diseases. Our Future Health aims to recruit five million adult volunteers, from all backgrounds, to participate in the research programme. By joining the voluntary research programme, people will be able to contribute to the most comprehensive picture of health ever captured in the UK.

We are targeting our actions for better, more equitable health

We work collaboratively with the NHS across the UK to improve cancer patients’ outcomes. Through numerous activities, we work together to improve patients and the public’s awareness of cancer signs and symptoms, to understand and improve cancer pathways, and to improve treatment uptake. Last year we produced a report working with the Less Survivable Cancer Taskforce titled ‘Levelling up: what does it mean for cancer in England?’ on the disparity in outcomes for these cancers, particularly in lower socio-economic groups. This year we’re seeking to build on this work by developing a toolkit in collaboration with cancer alliances and charity partners to support alliances in the Core20plus5 ambitions to build on, and complement, the excellent materials already produced by NHS England. Additionally, the 2023 MSD Grants Programme is available for Patient Advocacy Groups and healthcare organisations looking to address health inequalities and support the elimination of public health threats in the HIV, cancer and vaccines therapy areas. This programme will provide funding for projects designed to inform and empower patients, address health inequalities, and deliver improvements in patient outcomes and experience in the UK.

Strengthening healthcare resilience will require health and care leaders and policymakers to balance efficiency with long-term healthcare resilience, prioritise prevention and health equity, and learn from the successes and failures of the pandemic response to help inform approaches to future health challenges. At a time when political manifestos are being drawn up, we need to make sure there is a shared vision for delivering improved whole population health and health system resilience

GB-NON-07481 | Date of Preparation: May 2023

Our People

Smashing Stereotypes for British Science Week 2023

March 2023

The annual Smashing Stereotypes campaign is run by the British Science Association (BSA) during British Science Week, encouraging STEM employees and researchers to share stories about their day-to-day work. The BSA wants to showcase the diversity of the STEM workforce, the broad range of jobs and careers available, and that science can be for anyone.

With short films, interviews, and behind-the-scenes photography, the Smashing Stereotypes campaign profiled 5 MSD employees working across MRL, human and animal health, showcasing how they are smashing stereotypes in their roles as they work to save and improve lives.

By identifying and showcasing diverse role models, we can play our part in helping to break down misconceptions and barriers about who can be a scientist, and what they do

Check out our MSD colleagues’ profiles below to find out how they are Smashing Stereotypes!

MSD has provided partial funding towards the Smashing Stereotypes 2023 campaign

Viola Ntim

After studying pharmacy at the University of East Anglia, Viola completed her Masters degree in International Health Policy at the London School of Economics and Political Science.

At MSD she works as a health technology assessment and outcomes research (HTA&OR) manager, helping to decide whether new medicines are cost-effective through developing and designing models.

‘There’s a stereotype about careers in science or health that you have to work in a lab or hospital. In fact, there are plenty of office-based jobs in the medical field in which you can still have a huge impact on patients. As a Black woman, I am also an example that ethnic minorities can work in science.’

Read Viola’s full profile

Maya Hanspal

After a degree in medical neuroscience from the University of Sussex and a PhD in Chemistry at Cambridge, Maya joined MSD as a cell biologist.

Maya is based in the company’s London Bioscience Innovation centre in Kings Cross, investigating neurodegenerative diseases of ageing.

‘People often think that scientists must be incredibly analytical and mathematically minded. These skills are important, but I think creativity and thinking outside of the box are just as valuable. Science is all about problem-solving after all!

Read Maya’s full profile

Thomas Loseby-Taylor

Tom started working with animals at just 13. His first job was as a kennel assistant at a local veterinary hospital – a role he continued throughout school. At university, he studied Animal Welfare and Veterinary Science before becoming a veterinary nurse.

He is now Senior Pharmacovigilance Officer where he is also Rainbow Alliance Lead for Animal Health.

‘The stereotypical view of science, I think, is that it’s boring and predictable. My experience is the complete opposite: Yes, the fundamentals of science are chemistry, physics, and biology, but what’s possible is almost limitless.’

Read Thomas’ full profile

Jessica Jackson

Jessica grew up swimming competitively and competed at the 2018 Commonwealth Games in Australia as part of Team England.

She studied Biomedical Science at Plymouth University and during her time there was accepted as a Medical Affairs Associate at MSD as a student industry placement.

Jessica now works at MSD in the Medical Innovation team in Medical Affairs.

‘During my degree, I did a student industry placement at MSD. Initially, I felt like an imposter, but thanks to the support and mentorship I got at MSD, I returned to university with renewed purpose, completed my degree, and then went on to study for a part time Master’s degree at the University of Oxford – something I never thought would be possible for me.‘

Read Jessica’s full profile

Kuldip Sembhi

Kuldip started her working life as a junior lab technician in the NHS before becoming a clinical research technician. After starting a family, she switched careers in her thirties, taking a job in project management at MSD

She is now National Strategic Partnerships Programme Manager, heading up the company’s effort to eliminate Hepatitis C in England.

‘As a daughter of first-generation immigrants from India that came to the UK in the 1960s, I had been guided by my parents to follow a career in teaching so that it would be easier for me to take time off in the holidays when I had children. But following my father’s death, I started reading about cancer and the science behind how cells multiplied. It fascinated and inspired me.‘

Read Kuldip’s full profile

To learn more about the Smashing Stereotypes campaign, visit British Science Week’s website

GB-NON-07934 | August 2023

Partnerships

MSD launches Fifty Over 50: Giving people growing older with HIV a voice

July 2022

A unique listening project in partnership with several leading HIV organisations, with a mission to hear from people who are growing older with HIV.

Thanks to decades of clinical research, innovation and cross-sector collaboration, HIV has largely become a chronic condition in the UK. The UK has led the way in achieving the UNAIDS targets of 90% of people living with HIV knowing their HIV status, of those with a known HIV diagnosis 90% receiving treatment, and of those receiving treatment 90% having an undetectable viral load.

The progress which has been made through improvements in testing and treatment has been remarkable, and new diagnoses of HIV continue to decrease in the UK. However, as the number of people who are now growing older with HIV increases, this brings with it a host of new or additional challenges.

The Fifty Over 50 project, coordinated by MSD in collaboration with the Whole Person Care group of HIV community and professional organisations, is a unique listening exercise which set out to give people growing older with HIV a voice. Fifty Over 50 brings together first-hand accounts from a diverse range of people living with HIV aged 50+, and highlights how for many in the HIV community being well is about more than just viral suppression, it’s also about living well.

Ben Lucas, Managing Director for MSD in the UK and Ireland, commented:

“I am immensely proud that MSD have worked with all the individual contributors and organisations that form part of Fifty Over 50 – providing a platform for people to share their experiences and shine a light on the changes that are needed to support people living with HIV to live well across the entirety of their life.”

Learn more about Fifty Over 50 and hear what our contributors had to share in the e-book here.

GB-NON-06155 | Date of Preparation: July 2022 | Reapproval: May 2024